Data showed that prostate cancer patients are nearly three times more likely to have Lymphocytes T CD8+ in their stromal area than BPH patients (odds ratio = 2.8; χ2 = 4.3; p = .03) (Figure 5B (b1–b3)). Here, CD8A is linked to prostate carcinoma.